aTyr Pharma, Inc.
ATYRNASDAQHealthcare● Active
$0.44
$-0.03(-5.94%)
Market Cap$43348436
P/E Ratio—
52W High$7.29
52W Low$0.395
aTyr Pharma, Inc.（ATYR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ATYR · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19M | $0.23M | $0.35M | $10.39M | $0.00M |
| Cost of Revenue | $1.55M | $0.00M | $0.00M | $1.70M | $1.30M |
| Gross Profit | ($1.36M) | $0.23M | $0.35M | $8.69M | ($1.30M) |
| Gross Margin %(computed) | -717.37% | 100.00% | 100.00% | 83.68% | — |
| Operating Expenses | |||||
| R&D Expenses | $60.22M | $54.37M | $42.29M | $42.81M | $23.26M |
| G&A Expenses | $17.60M | $13.78M | $12.98M | $13.98M | $10.75M |
| Total Operating Expenses | $76.26M | $68.15M | $55.27M | $55.09M | $32.71M |
| Operating Income | ($77.63M) | ($67.91M) | ($54.92M) | ($46.40M) | ($34.02M) |
| Operating Margin %(computed) | — | — | — | -446.79% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($74.12M) | ($64.02M) | ($50.40M) | ($45.34M) | ($33.78M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($74.12M) | ($64.02M) | ($50.39M) | ($45.34M) | ($33.77M) |
| Net Margin %(computed) | — | — | — | -436.53% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.80 | $-0.86 | $-0.94 | $-1.60 | $-1.77 |
| Wtd Avg Shares | 92.99M | 74.26M | 53.61M | 28.42M | 19.08M |
| EBITDA | ($76.07M) | ($66.37M) | ($52.18M) | ($44.71M) | ($32.47M) |
| EBITDA Margin %(computed) | — | — | — | -430.47% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解aTyr Pharma, Inc.
关于aTyr Pharma, Inc.（ATYR）损益表
aTyr Pharma, Inc.（ATYR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ATYR实现营收$0.00B，毛利润($0.00B)（毛利率-717.37%），净利润($0.07B)（净利率-39009.47%）。
常见问题
ATYR · 4 问aTyr Pharma, Inc.（ATYR）2025财年营收为$0.00B，同比down19.1%。
ATYR revenueATYR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09